Non-Invasive Prenatal Testing (NIPT) Market Analysis By Application And Segment Forecasts To 2028

Author : Ketan Wagh | Published On : 22 Sep 2021

The non-invasive prenatal testing (NIPT) market size is expected to reach USD 6.56 billion by 2028 according to a new study by Polaris Market Research. The report “Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks); By Component (Consumables, Instruments, Software, Services); By Method; By Application; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market demand for non-invasive prenatal testing is expected to increase during the forecast period owing to growth in the occurrence of genetic disorders, increasing awareness regarding early fetal testing, and advancing maternal age. The significant market growth in healthcare infrastructure, technological advancements, and favorable regulations are some factors expected to provide growth opportunities during the forecast period.

The gestation period segment has been divided into 0-12 weeks, 13-24 weeks, 25-36 weeks. Testing performed for 13 – 24 weeks involves blood tests and ultrasound to detect genetic disorders and neural tube defects. Ultrasounds are also used in this period to examine the anatomy and associated disorders. There has been a high demand for consumables required during non-invasive prenatal testing. The rising awareness regarding fetal testing, coupled with technological advancements, supportive government regulations, and advanced healthcare infrastructure boosts the market growth. 

Get Sample PDF @ 

North America dominated the global NIPT market in 2020 and is expected to maintain its dominance over the forecast period. High living standards, significant investment in healthcare services, and increasing occurrence of chromosome abnormalities support market growth in this region. However, Asia-Pacific is expected to exhibit significant growth during the forecast period. Increasing population coupled with increasing awareness regarding fetal testing fuels growth in this region. Leading global players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries. 

On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain market share. Broadening of the product portfolio is another trend that is visible in the industry.

Some of the major market participants include Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., GE Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Inc., Sequenom, Qiagen N.V., Koninklijke Philips N.V., Natera, Inc., Beijing Genomics Institute, and Pacific Biosciences of California, Inc. 

Get Special Discount On this Research Report @ 

Polaris Market Research has segmented the non-invasive prenatal testing (NIPT) market report on the basis of gestation period, component, method, application, end-use, and region: 

Non-Invasive Prenatal Testing (NIPT) Gestation Period Outlook (Revenue, USD Million, 2016 – 2028)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

Non-Invasive Prenatal Testing (NIPT) Component Outlook (Revenue, USD Million, 2016 – 2028)

  • Consumables
  • Instruments
  • Software
  • Services

Non-Invasive Prenatal Testing (NIPT) Application Outlook (Revenue, USD Million, 2016 – 2028)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

Buy Now :

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intel ligence and in-depth business research services for our clientele spread across different enterprises. 

Contact Us:

Polaris Market Research

Phone: 1–646–568–9980